How Evening Primrose Oil Interacts with Weight-Loss Medications
Use caution · The honest verdict
Worth a conversation with your clinician
Evening primrose oil carries documented bleeding risk (a small human study found increased bleeding time in 9 of 12 patients on GLA) and may lower the seizure threshold — these are independent of GLP-1 drugs but matter for GLP-1 patients commonly on anticoagulants or with neurological history.
Evening primrose oil (EPO) is a popular supplement for inflammatory and hormonal conditions, but it comes with two under-discussed risks: increased bleeding tendency and a potential to lower the seizure threshold. While EPO has no direct pharmacokinetic interaction with GLP-1 medications like semaglutide or tirzepatide, the reduced fat intake and delayed gastric emptying caused by these drugs can significantly affect how well your body absorbs this fat-soluble oil. This guide breaks down the evidence behind the bleeding and seizure concerns, explains why absorption matters more on a GLP-1, and offers safer alternatives for most people.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Why they interact
Here's what actually happens when Evening Primrose Oil meets Anticoagulants/antiplatelets (bleeding risk); seizure threshold reduction (risk in predisposed); fat-soluble absorption affected by GLP-1-related reduced fat intake and delayed gastric emptying; mild additive GI upset — in plain language.
Evening primrose oil (EPO) is rich in gamma-linolenic acid (GLA, an omega-6 fatty acid). The bleeding risk is the highest-evidence concern: a small human study showed increased bleeding time in 9 of 12 patients receiving GLA supplementation; GLA inhibits thromboxane A2, reducing platelet aggregation. This creates an additive bleeding risk with anticoagulants (warfarin) or antiplatelet drugs (aspirin, clopidogrel). The seizure-threshold concern has been reported in case reports of individuals predisposed to epilepsy; mechanism is not fully elucidated. As a fat-soluble supplement, EPO's absorption depends on co-ingested dietary fat — GLP-1 drugs slow gastric emptying and GLP-1 patients typically eat less fat due to appetite suppression; this could reduce EPO's effective dose. No direct GLP-1 pharmacokinetic interaction exists. Mild GI upset is possible and additive with GLP-1 baseline GI burden.
What the research says
Bleeding risk documented in small human GLA study (9/12 patients, cited by MSK); seizure risk from case reports; no GLP-1 co-administration study found; fat-soluble absorption consideration is theoretical based on GLP-1 pharmacodynamics
Does it depend on which GLP-1?
The picture can differ slightly across medications. Here's what to know for each.
Semaglutide (Ozempic, Wegovy)
No documented direct interaction with semaglutide; EPO can increase bleeding risk and may cause GI upset; fat-soluble absorption may be affected by reduced dietary fat and delayed gastric emptying on GLP-1
Tirzepatide (Mounjaro, Zepbound)
Same rationale as semaglutide — no direct interaction, but absorption, bleeding, and GI concerns apply equally
When and how to take it
Take with food (largest fat-containing meal) to maximize absorption; caution if on blood thinners or anticoagulants — discuss with prescriber; caution if personal or family history of seizures; stop 2 weeks before any surgical procedure
Signs to watch for
- Unusual bruising or prolonged bleeding from cuts
- Spontaneous bleeding (gums, nose)
- Seizures (especially in those with risk factors)
- Worsening GI upset beyond baseline GLP-1 effects
What Evening Primrose Oil Is and Why GLP-1 Users Take It
Evening primrose oil is pressed from the seeds of Oenothera biennis and is one of the richest natural sources of gamma-linolenic acid (GLA), an omega-6 fatty acid your body converts to dihomo-gamma-linolenic acid (DGLA). DGLA serves as a precursor to anti-inflammatory prostaglandins, which is the biochemical basis for EPO's reputation as an inflammation-calming supplement.
People reach for EPO for a range of reasons: premenstrual syndrome (PMS) breast pain and mood symptoms, menopausal hot flashes, eczema and atopic dermatitis, and rheumatoid arthritis. The evidence for these uses is mixed — some small trials show modest benefit for cyclical mastalgia and certain skin conditions, while larger reviews find insufficient evidence for most other indications.
GLP-1 users often seek out EPO for conditions that frequently co-occur with obesity: systemic low-grade inflammation, hormone-related symptoms that can shift during rapid weight loss, and skin changes. The logic is understandable — if you're already addressing metabolic health through a GLP-1 medication, an anti-inflammatory supplement feels like a natural complement. But the reasons people take EPO during GLP-1 weight loss are often distinct from what the evidence actually supports, and the risk profile deserves a closer look than most supplement guides provide.
Bottom line
EPO's anti-inflammatory use case is plausible but evidence is mixed and indication-specific; the reasons people take it during GLP-1 weight loss are often distinct from what the evidence supports.
The Bleeding Risk: What That GLA Study Actually Found
The bleeding concern with evening primrose oil is not theoretical — it comes from a small but striking human study cited by Memorial Sloan Kettering's integrative medicine database. In that study, 9 out of 12 patients receiving GLA supplementation showed measurably increased bleeding time. That is a 75% response rate in a small sample, which makes it a signal worth taking seriously even though the study size limits how broadly we can generalize.
The mechanism is fairly well understood: GLA inhibits thromboxane A2, a compound that helps platelets clump together to form clots. When thromboxane A2 production drops, platelet aggregation slows, and bleeding time lengthens. This is pharmacologically similar to how low-dose aspirin works, which is precisely why combining EPO with actual antiplatelet or anticoagulant drugs creates an additive risk. If you are already taking warfarin, clopidogrel, or daily aspirin, adding EPO is like stacking a second, unregulated blood thinner on top of your prescribed one.
When does a longer bleeding time actually matter in real life? It matters most in three scenarios: before surgery (where even modest bleeding-time increases can complicate procedures), during accidental injury, and in people who already have a bleeding tendency or are on anticoagulants. The standard precautionary guidance — stopping EPO two weeks before any scheduled surgery — exists for good reason. It is also worth noting that this bleeding risk is mechanistically distinct from the better-known omega-3 fish oil bleeding risk, though the practical implication is similar: both supplements make your blood slightly less likely to clot.
- 9 of 12 patients on GLA showed increased bleeding time in a human study
- Mechanism: GLA inhibits thromboxane A2, reducing platelet aggregation
- Additive risk with warfarin, clopidogrel, aspirin, and NSAIDs
- Stop EPO at least 2 weeks before any surgical procedure
Bottom line
Increased bleeding time in 9 of 12 patients is not a minor signal — if you're on warfarin, aspirin, or clopidogrel, this combination warrants prescriber disclosure.
Seizure Risk and Who Should Be Extra Cautious
The seizure concern with evening primrose oil is less well-characterized than the bleeding risk but appears in enough case reports to warrant caution for specific populations. The exact mechanism is not fully elucidated — hypotheses involve GLA's downstream prostaglandin effects on the central nervous system, but the data is not robust enough to draw firm conclusions. What we do know is that seizures have been reported in individuals taking EPO who either had a pre-existing seizure disorder or were taking medications that independently lower the seizure threshold.
This matters for GLP-1 patients because obesity is frequently comorbid with conditions treated by medications that lower the seizure threshold. Bupropion (Wellbutrin), commonly prescribed for depression and smoking cessation, is one such drug. Tramadol, certain antipsychotics, and some antibiotics also fall into this category. If you are on a GLP-1 medication and also take bupropion — a combination that is not uncommon in weight-management contexts — the addition of EPO introduces a seizure risk that neither your GLP-1 prescriber nor your psychiatrist may have considered.
For the general population without these risk factors, the absolute seizure risk from EPO appears very low. But the calculus shifts meaningfully if you have a personal or family history of epilepsy, a history of febrile seizures, or are on any medication known to reduce the seizure threshold. In those cases, the precautionary principle suggests avoiding EPO unless a physician has specifically weighed in.
- Case reports link EPO to seizures in predisposed individuals
- Mechanism not fully understood; may involve CNS prostaglandin effects
- Higher risk if you take bupropion, tramadol, or certain antipsychotics
- Personal or family history of epilepsy warrants avoiding EPO
Bottom line
The seizure risk is low in the general population but shifts to a meaningful concern if you already take medications that lower the seizure threshold.
Fat-Soluble Supplement Absorption on a GLP-1: How Reduced Fat Intake Affects EPO
Evening primrose oil is, as the name suggests, an oil — it is fat-soluble and requires co-ingested dietary fat for proper absorption. This is not a minor detail; it is a pharmacological necessity. When you swallow an EPO capsule on an empty stomach or with a fat-free meal, a significant portion of the GLA passes through your digestive system unabsorbed. The standard guidance for any fat-soluble supplement is to take it with your largest fat-containing meal of the day.
GLP-1 medications complicate this picture in two ways. First, semaglutide and tirzepatide suppress appetite, and one of the most consistent dietary shifts seen in GLP-1 users is a reduction in total fat intake — people simply eat less of everything, and fatty foods in particular become less appealing or less tolerable. Second, GLP-1 drugs slow gastric emptying, meaning the supplement sits in your stomach longer before reaching the small intestine where fat absorption primarily occurs. The net effect is that the effective dose of EPO you absorb on a GLP-1 may be lower than what the label suggests.
The practical fix is straightforward but requires intention: take your EPO with the meal of the day that contains the most fat. If your breakfast includes eggs and avocado, that is a better absorption partner than a low-fat lunch of grilled chicken and steamed vegetables. This same absorption challenge applies to other fat-soluble supplements commonly taken alongside GLP-1s — CoQ10, vitamin K2, astaxanthin, and fat-soluble vitamins A, D, E, and K all face the same reduced-absorption dynamic.
- EPO is fat-soluble; absorption requires co-ingested dietary fat
- GLP-1 appetite suppression typically reduces total fat intake
- Delayed gastric emptying on GLP-1s further complicates absorption timing
- Take EPO with your largest fat-containing meal of the day
- Same absorption challenge applies to CoQ10, vitamin K2, and fat-soluble vitamins
Bottom line
Taking EPO with a fat-containing meal is not optional — it is a pharmacological necessity for adequate absorption, and this matters more on a GLP-1 where fat intake tends to drop.
Better Evidence, Lower Risk: Comparing EPO to Omega-3s for Inflammation
If you are taking evening primrose oil for general anti-inflammatory purposes during GLP-1 weight loss, it is worth asking whether a different supplement would serve you better. Omega-3 fatty acids (EPA and DHA from fish oil) have a substantially stronger evidence base for most inflammatory indications — cardiovascular risk reduction, rheumatoid arthritis, and general systemic inflammation all have larger, more consistent trial data behind omega-3s than GLA has for any indication.
Omega-3s do carry their own bleeding risk through a similar antiplatelet mechanism, but that risk is far better characterized, with clear dose-response relationships and established clinical guidance. You know what you are getting with fish oil in a way that is less true for EPO. The cardiovascular benefits of omega-3s are also directly relevant to the GLP-1 population, where heart health is often a parallel concern alongside weight management.
That said, EPO does have specific niches where it outperforms omega-3s in the evidence. Cyclical mastalgia (breast pain related to the menstrual cycle) and certain PMS symptom clusters have modest but real trial support for GLA that EPA/DHA cannot claim. If you are taking EPO for one of these specific, evidence-supported indications, the risk-benefit calculus may still favor it — provided you are not in the bleeding-risk or seizure-risk populations. For everyone else, an honest assessment suggests omega-3 fish oil is the better-evidenced, better-characterized choice.
- Omega-3 (EPA/DHA) has stronger anti-inflammatory evidence than GLA for most indications
- Omega-3 bleeding risk is better characterized with clearer dose-response data
- EPO has specific advantages for cyclical mastalgia and some PMS symptoms
- For general inflammation during GLP-1 weight loss, fish oil is the safer bet
Bottom line
For most inflammatory purposes, omega-3 fish oil has a better evidence base and a better-characterized risk profile than EPO; consider whether EPO is the right choice for your specific indication.
What most pages leave out
Most EPO supplement content does not mention the bleeding study (MSK cites 9/12 patients — that is a notable signal); competitors also skip the seizure risk entirely; both deserve honest disclosure.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
There is no documented direct interaction between evening primrose oil and semaglutide (Ozempic). However, EPO carries an independent bleeding risk that becomes additive if you are also on anticoagulants or antiplatelet medications. Additionally, GLP-1 medications reduce appetite and slow gastric emptying, which can decrease absorption of fat-soluble supplements like EPO. Take it with a fat-containing meal and inform your prescriber if you are on any blood-thinning medications.
The bleeding risk from evening primrose oil is independent of semaglutide — it comes from GLA's inhibition of thromboxane A2, which reduces platelet aggregation. A small human study found increased bleeding time in 9 of 12 patients taking GLA. This risk becomes clinically significant if you are also taking warfarin, clopidogrel, aspirin, or regular NSAIDs. Semaglutide itself does not amplify the bleeding mechanism, but the combination of EPO and any antiplatelet or anticoagulant drug warrants a conversation with your prescriber.
Mild additive GI upset is possible when combining evening primrose oil with tirzepatide, since both can independently cause nausea, stomach discomfort, or loose stools. The best approach is to introduce EPO during a stable GLP-1 maintenance phase rather than during dose escalation, when your GI system is already adapting to the medication. If you notice worsening nausea or diarrhea after starting EPO, discontinue it and see if symptoms resolve before reintroducing at a lower dose.
Yes, GLP-1 medications can reduce evening primrose oil absorption through two mechanisms. First, appetite suppression typically leads to lower total dietary fat intake, and EPO requires co-ingested fat for adequate absorption. Second, delayed gastric emptying means the oil sits in the stomach longer before reaching the small intestine where fat absorption occurs. To compensate, always take EPO with your largest fat-containing meal of the day rather than on an empty stomach or with a low-fat meal.
The seizure risk from evening primrose oil is low in the general population but becomes a meaningful concern if you have a personal or family history of epilepsy, a history of febrile seizures, or take medications that lower the seizure threshold — such as bupropion (Wellbutrin), tramadol, or certain antipsychotics. Semaglutide itself does not affect seizure threshold, but the combination of EPO with a seizure-threshold-lowering medication is one your prescriber should know about.
For most people on Wegovy seeking anti-inflammatory support, fish oil (omega-3 EPA/DHA) is the better choice. It has a substantially stronger evidence base for cardiovascular and inflammatory indications, a better-characterized safety profile, and directly relevant heart-health benefits for the GLP-1 population. Evening primrose oil has specific advantages for cyclical mastalgia and certain PMS symptoms where the GLA evidence is modestly positive, but for general inflammation, fish oil is the more evidence-supported option.
Yes — you should stop evening primrose oil at least two weeks before any scheduled surgical procedure, regardless of whether you are on a GLP-1 medication. The bleeding risk from EPO is independent of GLP-1 use and stems from GLA's antiplatelet effects. This is standard precautionary guidance for any supplement with documented bleeding risk, and it applies equally whether you are taking semaglutide, tirzepatide, or neither.
Watch for unusual or easy bruising, prolonged bleeding from minor cuts, spontaneous gum or nose bleeding, and any seizure activity — especially if you have risk factors. Also monitor for worsening GI symptoms beyond your baseline GLP-1 side effects, such as new or increased nausea, stomach pain, or diarrhea after starting EPO. If any of these signs appear, stop the supplement and contact your prescriber.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
How Fish Oil / Omega-3 Fatty Acids Interacts With Weight Loss Medications
Fish oil has no direct drug interaction with semaglutide or tirzepatide, but GI upset and high-dose antiplatelet effects matter. A practical, honest guide.
Read moreHow Borage Oil Interacts with Weight-Loss Medications
Borage oil has no direct interaction with GLP-1 drugs, but its GLA content may increase bleeding risk with anticoagulants. Learn about PA contamination and safe use.
Read moreHow Flaxseed Oil Interacts with Weight-Loss Medications
Flaxseed oil has no direct interaction with GLP-1s, but its antiplatelet effect warrants caution with blood thinners. Learn why ALA isn't a substitute for fish oil.
Read moreHow CBD Oil (Cannabidiol) Interacts with Weight-Loss Medications
CBD doesn't directly interact with semaglutide or tirzepatide, but it potently inhibits CYP450 enzymes, affecting many common co-medications. Learn the real risks.
Read moreHow MCT Oil (Medium Chain Triglycerides) Interacts with Weight Loss Medications
MCT oil can worsen diarrhea and cramping from GLP-1 meds like semaglutide. Learn why the GI risks compound, and how to use it safely if you choose to.
Read moreHow Cod Liver Oil Interacts with Weight-Loss Medications
Cod liver oil has no direct interaction with GLP-1s, but its preformed vitamin A and D can silently stack to toxic levels with multivitamins. Learn the real risks.
Read moreOn a GLP-1, or thinking about one?
If you take Evening Primrose Oil alongside a GLP-1, it helps to have your medication managed by a clinician who sees the whole picture.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
Important: This page is general information, not medical advice, and it does not account for your health or medications. Supplements can interact with prescription drugs in ways that depend on your dose and situation. Curex offers compounded GLP-1 medications through licensed clinicians — compounded medications are not FDA-approved, and the FDA has not evaluated their safety or efficacy. The supplement discussed here is not a Curex product. Always talk to your pharmacist or prescriber before combining a supplement with any weight-loss medication.
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.